Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Crinetics Pharmaceuticals Inc shares valued at $53,302 were sold by Betz Stephen F. on Sep 10 ’24. At $51.50 per share, Betz Stephen F. sold 1,035 shares. The insider’s holdings dropped to 68,576 shares worth approximately $3.62 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Betz Stephen F. purchased 1,035 shares, netting a total of over 53,301 in proceeds.
Before that, Betz Stephen F. had sold 3,000 shares from its account. In a trade valued at $159,570, the Chief Scientific Officer traded Crinetics Pharmaceuticals Inc shares for $53.19 each. Upon closing the transaction, the insider’s holdings decreased to 3,000 shares, worth approximately $3.67 million.
As published in their initiating research note from Citigroup on March 06, 2024, Crinetics Pharmaceuticals Inc [CRNX] has been a Buy and the price target has been revised to $68. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid January. As of December 21, 2023, Jefferies has initiated its “Hold” rating for CRNX.
Analyzing CRNX Stock Performance
During the last five days, there has been a surge of approximately 4.00%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have jumped approximately 48.31%. Shares of the company reached a 52-week high of $55.78 on 07/23/24 and a 52-week low of $33.67 on 01/05/24. A 50-day SMA is recorded $52.35, while a 200-day SMA reached $44.38. Nevertheless, trading volume fell to 0.78 million shares from 0.53 million shares the previous day.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 51.92, which, if violated, would cause prices to drop to 51.08. In the upper region, resistance lies at 53.76. The next price resistance is at 54.75. RSI (Relative Strength Index) is 52.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.09, which suggests the price will increase in the coming days. Percent R is at 39.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
#####
#####
